Cargando…
Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review
Tuberous sclerosis complex (TSC) is a rare autosomal dominant neurocutaneous syndrome. It is manifested mainly in cutaneous lesions, epilepsy and the emergence of hamartomas in several tissues and organs. The disease sets in due to mutations in two tumor suppressor genes: TSC1 and TSC2. The authors...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957184/ https://www.ncbi.nlm.nih.gov/pubmed/36833359 http://dx.doi.org/10.3390/genes14020433 |
_version_ | 1784894763760091136 |
---|---|
author | Jurca, Claudia Maria Kozma, Kinga Petchesi, Codruta Diana Zaha, Dana Carmen Magyar, Ioan Munteanu, Mihai Faur, Lucian Jurca, Aurora Bembea, Dan Severin, Emilia Jurca, Alexandru Daniel |
author_facet | Jurca, Claudia Maria Kozma, Kinga Petchesi, Codruta Diana Zaha, Dana Carmen Magyar, Ioan Munteanu, Mihai Faur, Lucian Jurca, Aurora Bembea, Dan Severin, Emilia Jurca, Alexandru Daniel |
author_sort | Jurca, Claudia Maria |
collection | PubMed |
description | Tuberous sclerosis complex (TSC) is a rare autosomal dominant neurocutaneous syndrome. It is manifested mainly in cutaneous lesions, epilepsy and the emergence of hamartomas in several tissues and organs. The disease sets in due to mutations in two tumor suppressor genes: TSC1 and TSC2. The authors present the case of a 33-year-old female patient registered with the Bihor County Regional Center of Medical Genetics (RCMG) since 2021 with a TSC diagnosis. She was diagnosed with epilepsy at eight months old. At 18 years old she was diagnosed with tuberous sclerosis and was referred to the neurology department. Since 2013 she has been registered with the department for diabetes and nutritional diseases with a type 2 diabetes mellitus (T2DM) diagnosis. The clinical examination revealed: growth delay, obesity, facial angiofibromas, sebaceous adenomas, depigmented macules, papillomatous tumorlets in the thorax (bilateral) and neck, periungual fibroma in both lower limbs, frequent convulsive seizures; on a biological level, high glycemia and glycated hemoglobin levels. Brain MRI displayed a distinctive TS aspect with five bilateral hamartomatous subependymal nodules associating cortical/subcortical tubers with the frontal, temporal and occipital distribution. Molecular diagnosis showed a pathogenic variant in the TSC1 gene, exon 13, c.1270A>T (p. Arg424*). Current treatment targets diabetes (Metformin, Gliclazide and the GLP-1 analog semaglutide) and epilepsy (Carbamazepine and Clonazepam). This case report presents a rare association between type 2 diabetes mellitus and Tuberous Sclerosis Complex. We suggest that the diabetes medication Metformin may have positive effects on both the progression of the tumor associated with TSC and the seizures specific to TSC and we assume that the association of TSC and T2DM in the presented cases is accidental, as there are no similar cases reported in the literature. |
format | Online Article Text |
id | pubmed-9957184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99571842023-02-25 Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review Jurca, Claudia Maria Kozma, Kinga Petchesi, Codruta Diana Zaha, Dana Carmen Magyar, Ioan Munteanu, Mihai Faur, Lucian Jurca, Aurora Bembea, Dan Severin, Emilia Jurca, Alexandru Daniel Genes (Basel) Case Report Tuberous sclerosis complex (TSC) is a rare autosomal dominant neurocutaneous syndrome. It is manifested mainly in cutaneous lesions, epilepsy and the emergence of hamartomas in several tissues and organs. The disease sets in due to mutations in two tumor suppressor genes: TSC1 and TSC2. The authors present the case of a 33-year-old female patient registered with the Bihor County Regional Center of Medical Genetics (RCMG) since 2021 with a TSC diagnosis. She was diagnosed with epilepsy at eight months old. At 18 years old she was diagnosed with tuberous sclerosis and was referred to the neurology department. Since 2013 she has been registered with the department for diabetes and nutritional diseases with a type 2 diabetes mellitus (T2DM) diagnosis. The clinical examination revealed: growth delay, obesity, facial angiofibromas, sebaceous adenomas, depigmented macules, papillomatous tumorlets in the thorax (bilateral) and neck, periungual fibroma in both lower limbs, frequent convulsive seizures; on a biological level, high glycemia and glycated hemoglobin levels. Brain MRI displayed a distinctive TS aspect with five bilateral hamartomatous subependymal nodules associating cortical/subcortical tubers with the frontal, temporal and occipital distribution. Molecular diagnosis showed a pathogenic variant in the TSC1 gene, exon 13, c.1270A>T (p. Arg424*). Current treatment targets diabetes (Metformin, Gliclazide and the GLP-1 analog semaglutide) and epilepsy (Carbamazepine and Clonazepam). This case report presents a rare association between type 2 diabetes mellitus and Tuberous Sclerosis Complex. We suggest that the diabetes medication Metformin may have positive effects on both the progression of the tumor associated with TSC and the seizures specific to TSC and we assume that the association of TSC and T2DM in the presented cases is accidental, as there are no similar cases reported in the literature. MDPI 2023-02-08 /pmc/articles/PMC9957184/ /pubmed/36833359 http://dx.doi.org/10.3390/genes14020433 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Jurca, Claudia Maria Kozma, Kinga Petchesi, Codruta Diana Zaha, Dana Carmen Magyar, Ioan Munteanu, Mihai Faur, Lucian Jurca, Aurora Bembea, Dan Severin, Emilia Jurca, Alexandru Daniel Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review |
title | Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review |
title_full | Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review |
title_fullStr | Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review |
title_full_unstemmed | Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review |
title_short | Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review |
title_sort | tuberous sclerosis, type ii diabetes mellitus and the pi3k/akt/mtor signaling pathways—case report and literature review |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957184/ https://www.ncbi.nlm.nih.gov/pubmed/36833359 http://dx.doi.org/10.3390/genes14020433 |
work_keys_str_mv | AT jurcaclaudiamaria tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview AT kozmakinga tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview AT petchesicodrutadiana tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview AT zahadanacarmen tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview AT magyarioan tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview AT munteanumihai tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview AT faurlucian tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview AT jurcaaurora tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview AT bembeadan tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview AT severinemilia tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview AT jurcaalexandrudaniel tuberoussclerosistypeiidiabetesmellitusandthepi3kaktmtorsignalingpathwayscasereportandliteraturereview |